Pramipexole versus dual release levodopa in restless legs syndrome: A double blind, randomised, cross-over trial

Swiss Medical Weekly

Volumn 141, Issue NOVEMBER, 2011, Pages

  Bassetti, Claudio L ^a   Bornatico, Fiammetta ^b   Fuhr, Peter ^c   Schwander, Jürg ^d   Kallweit, Ulf ^a   Mathis, Johannes ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Ospedale Civico Lugano   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Clinic Zurzach   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Dual release levodopa; Periodic limb movements; Pramipexole; Restless legs syndrome

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOMPERIDONE; LEVODOPA; PRAMIPEXOLE; BENSERAZIDE; BENSERAZIDE, LEVODOPA DRUG COMBINATION; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOL;

ADULT; AGED; ARTICLE; ASTHENIA; BEDTIME DOSAGE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; EDEMA; EPWORTH SLEEPINESS SCALE; FEMALE; HALLUCINATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOTENSION; INTERNATIONAL RESTLESS LEGS SYNDROME STUDY GROUP RATING SCALE; INVOLUNTARY MOVEMENT; LABORATORY TEST; MALE; MEDICAL PARAMETERS; MULTICENTER STUDY; NAUSEA; NIGHTMARE; PERIODIC LIMB MOVEMENT DISORDER; PERIODIC LIMB MOVEMENT WHILE IN BED INDEX; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REBOUND; RESTLESS LEGS SYNDROME; SHORT FORM 36; SIDE EFFECT; SLEEP ATTACK; SLEEP DISORDER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER; VITAL SIGN; VOMITING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; SLEEP;

ADULT; AGED; BENSERAZIDE; BENZOTHIAZOLES; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SLEEP; TREATMENT OUTCOME;

EID: 82655178467     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13274     Document Type: Article

References (27)

1. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18:128-47. (Pubitemid 32549908)
2. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121-32. (Pubitemid 36527232)
3. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61-5. (Pubitemid 27032881)
4. Clavadetscher SC, Gugger M, Bassetti CL. Restless legs syndrome: clinical experience with long-term treatment. Sleep Med. 2004;5:495-500. (Pubitemid 39194061)
5. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:557-9.
6. Vignatelli L, Billiard M, Clarenbach P, Garcia-Borreguero D, Kaynak D, Liesiene V, Trenkwalder C, Montagna P. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol. 2006;13:1049-65. (Pubitemid 44434310)
7. Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: a doubleblind, randomized, multicenter, crossover trial. Sleep. 1999;22:1073-81. (Pubitemid 30173982)
8. Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 1999;52(2):285-90. (Pubitemid 29059053)
9. Becker PM, Ondo W, Sharon D. Encouraging initial response of restless legs syndrome to pramipexole. Neurology. 1998;51:1221-3. (Pubitemid 28473440)
10. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by PPX: a double-blind randomized trial. Neurology. 1999;52(5):938-43. (Pubitemid 29161600)
11. Montplaisir J, Denesle R, Petit D. PPX in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol. 2000;7(Suppl 1):27-31. (Pubitemid 32260559)
12. Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study - the PRELUDE study. Sleep Med. 2006;7:407-17. (Pubitemid 44130411)
13. Staedt J, Wassmuth F, Ziemann U, Hajak G, Rüther E, Stoppe G. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa. J Neurol Transm. 1997;104:461-8. (Pubitemid 27379902)
14. Trenkwalder C, Benes H, Grote L, Happe S, Hoegl B, Mathis J, et al. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial. Mov Disord. 2007;22:696-703. (Pubitemid 46800141)
15. Descombes S, Bonnet AM, Gasser UE, Thalamas C, Dingemanse J, Arnulf I, et al. Dual-Release Formulation, a novel principle in the Levodopa treatment of Parkinson's Disease. Neurology. 2001; 56:1239-42. (Pubitemid 32405727)
16. Bonnet M, Carley D, Carskadon M, Easton P, Guilleminault C, Harper R, et al. Atlas Task Force. Recording and scoring leg movements. APSS Natl Mtg, 1992 Sleep. 1993;16:749-59.
17. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-5.
18. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand. 1983;67:361-70. (Pubitemid 13098606)
19. Gorny SW, Allen RP, Krausman DT, Earley CJ. Evaluation of the PAMRL system for the detection of periodic leg movements during sleep. 12th Ann Mtg of the Associated Professional Sleep Societies, New Orleans, 18-23 June 1998.
20. Sforza E, Mathis J, Bassetti C. The PAM-RL ambulatory device for detection of periodic leg movements: a validation study. Sleep Medicine. 2005;6:407-13. (Pubitemid 41245362)
21. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics. 1972;28(2):577-84.
22. Trenkwalder C, Hundemer H-P, Lledo A, Swieca J, Polo O, Wetter TC, et al. Efficacy of pergolide in the treatment of restless legs syndrome: The PEARLS Study. Neurology. 2004;62:1391-7. (Pubitemid 38526054)
23. Adler CA, Hauser RA, Sethi K, Cavines JN, Marlor L, Anderson WM, Hentz JG. Ropinirole for restless legs syndrome: A Placebo controlled crossover trial. Neurology. 2004;62:1405-7. (Pubitemid 38526058)
24. Winkelman JW, Sethi KD, Kushida CA, Becker PM, Koester J, Cappola JJ and Reess J. Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006; 67:1034-9. (Pubitemid 44454599)
25. Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T, et al. A randomized controlled study with pergolide in patients with restless legs syndrome. Neurology. 1999;52:944-50. (Pubitemid 29161601)
26. Stiansny-Kolster K, Benes H, Peglau I, Hornyak M, Holinka B, Wessel K, et al. Effective carbergoline treatment in idiopathic restless legs syndrome. Neurology. 2004;63:2272-9. (Pubitemid 40024336)
27. Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: a doubleblind, randomized, multicenter, crossover trial. Sleep. 1999;22:1073-81. (Pubitemid 30173982)